Clinical Trials Logo

Filter by:
NCT ID: NCT00933413 Completed - Hygiene Clinical Trials

Dermacyd Silver Frutal (Lactic Acid) - Acceptability.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.

NCT ID: NCT00933257 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of photoirritation and potential photosensitization of the product Dermacyd PHDESILSTYFR.

NCT ID: NCT00933075 Completed - Hygiene Clinical Trials

Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd Silver Frutal.

NCT ID: NCT00932984 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Photo Evaluation

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of photoirritation and potential photosensitization of the product Dermacyd Silver Floral.

NCT ID: NCT00932945 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.

NCT ID: NCT00932893 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Start date: September 2009
Phase: Phase 3
Study type: Interventional

This is a Phase 3 trial comparing the safety and anti-tumor activity of PF-02341066 versus pemetrexed or docetaxel in patients with advanced non-small cell lung cancer with specific gene profile involving the ALK gene after failure of one previous chemotherapy regimen that included one platinum drug.

NCT ID: NCT00932802 Completed - Bronchitis, Chronic Clinical Trials

Greatest International Antiinfective Trial With Avelox

GIANT
Start date: February 2004
Phase: N/A
Study type: Observational

The observation period for each patient covered an initial treatment period with Avelox® plus optional 2 long-term follow-up periods (6 and 12 months).For each patient, the physician documented data at any initial visit (baseline) and at least one short-term follow-up visit (=initial treatment period).Optionally, long-term follow-ups (6 and 12 months) were documented, and a patient questionnaire was filled in.

NCT ID: NCT00932451 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Start date: January 2010
Phase: Phase 2
Study type: Interventional

This is a Phase 2 trial that will evaluate the safety and efficacy of PF-02341066 in patients with advanced non-small cell lung cancer with a specific gene profile involving the ALK gene. This trial will also allow patients from a Phase 3 trial who received standard of care chemotherapy (Study A8081007) to receive PF-02341066.

NCT ID: NCT00931905 Completed - Lead Poisoning Clinical Trials

Homeopathic Preparation Plumbum Metallicum for Lead Poisoning

Start date: n/a
Phase: Phase 4
Study type: Interventional

Saturnism, or lead poisoning, is defined by clinical symptoms (affecting primarily the nervous, hematopoietic, gastrointestinal, cardiovascular, musculoskeletal, renal and reproductive systems) compatible with exposure, in the short or long term, to lead or to its compounds, and can manifest as acute or chronic symptoms, pursuant to the intensity and duration of the signs and symptoms. Measuring serum concentration is the primary method for diagnosing and accompanying exposed workers. Presently, elevated lead counts are reversed by using drugs whose effectiveness is contested on various fronts. Experimental studies shows the efficacy of homeopathic preparations in controlling blood lead levels in laboratory animals, creating the need for controlled studies that evaluate the effectiveness and safety of these preparations in humans.The objective of this study was evaluate the effectiveness of the homeopathic preparation Plumbum metallicum in reducing the blood lead level of workers exposed to this metal.

NCT ID: NCT00931853 Completed - Constipation Clinical Trials

Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).

Start date: September 2010
Phase: Phase 3
Study type: Interventional

Primary Objective: - To evaluate the clinical efficacy of Naturetti (jelly sugar free) - To test medication on subjects who suffer chronic functional constipation in 30 days use. Secondary Objectives: - To demonstrate the clinical tolerability when daily used (repeated doses) of the components of the study drug. The components will be evaluated by the adverse events occurrence classified by possibly related, probably related and definitely related - To demonstrate the clinical tolerability of the study medication by the continuous use during the second phase study - To identify any adverse events related to the study drug - To identify any drug interaction.